ITLN1 and neoplasm: Tumor clinical stage T II and positive LN involvement, as well as tumor histologic grade III, were associated with CD295 rs6700986 CC and CT genotypes, as well as ITLN1 rs952804 mutant CT cases (p ≤ 0.05) (Table 3).